Cardiothoracics
Question 8 (Sept 2019)
This question regards cardioplegia solution
​
a) Name 3 reasons cardioplegia is used in cardiac surgery? (3 marks)
​
b) What is the typical composition of cardioplegia solution? (4 marks)
​
c) Name 5 physiological effects of cardioplegia solution on the myocardium? (5 marks)
​
d) Name 2 routes by cardioplegia solution be administered? (2 marks)
​
e) Name 6 possible complications of cardioplegia solution administration? (6 marks)
Question 8 (March 2019)
a) Describe three ways a patient with dilated cardiomyopathy (DCM) could present (3 marks)
b) Name 3 pharmacological management options for a patient with DCM (3 marks)
​
c) Name 2 non-pharmacological management options for a patient with DCM (2 marks)
​
d) List 2 predictors of poor outcome in patients with DCM undergoing surgery (2 marks)
​
e) What are the haemodynamic goals when anaesthetising patients with DCM (4 marks)
​
f) What measures would you take to achieve these haemodynamic goals during anaesthesia (6 marks)
Question 5 (September 2018)
​
a) Name and explain 3 ways to quantify preoperatively risks associated with lung resection (6 marks)
​
b) Name 6 factors that can lead to the development of high airway pressures during one lung ventilation (OLV) (6 marks)
​
c) Outline how you would manage the development of hypoxaemia during OLV (8 marks)
​
​
Question 3 (March 2018)
​
a) List 5 possible indications for the insertion of cardiac implantalbe electronic devices (5 marks)
​
b) What 5 factors would you check preoperatively in a patient with these types of devices? (5 marks)
​
c) Outline 6 relevant pieroperative mangement considerations of a patient with an automatc implantable cardioversion defibrillator who is having elective surgery under general anaesthetic (6 marks)
​
d) A patient with a pacemaker develops severe bradycardia with circulatory compromiseand no pacemaker response. What 4 specific therapies should you consider in this situation? (4 marks)